73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H

Scientists develop DNA molecule that may one day be used as 'vaccine' for prostate cancer

by City of HopeDNA drug (CpG-STAT3 antisense, red) is penetrating human prostate cancer cells within 15 minutes of exposure (CpG-STAT3 antisense, red; intracellular vesicles, green). Credit: City of H
Few women perceive breast density as a cancer risk factor

Few women perceive breast density as a cancer risk factor

by Lori SolomonMost women perceive family history as the greatest risk factor for breast cancer, according to a study published online Jan. 23 inJAMA Network Open.Laura B. Beidler, from Dartmout

Few women perceive breast density as a cancer risk factor

by Lori SolomonMost women perceive family history as the greatest risk factor for breast cancer, according to a study published online Jan. 23 inJAMA Network Open.Laura B. Beidler, from Dartmout
Physicians IDs barriers to 'no antibiotic' strategy for pediatric viral pneumonia

Physicians IDs barriers to 'no antibiotic' strategy for pediatric viral pneumonia

by Elana GotkineThere are considerable barriers relating to implementation of a "no antibiotic" strategy for mild community-acquired pneumonia (CAP) in children, according to a study publish

Physicians IDs barriers to 'no antibiotic' strategy for pediatric viral pneumonia

by Elana GotkineThere are considerable barriers relating to implementation of a "no antibiotic" strategy for mild community-acquired pneumonia (CAP) in children, according to a study publish
New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO
A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint
Discovery could lead to better treatment for leukemia

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my

Discovery could lead to better treatment for leukemia

by University of Illinois at ChicagoBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaPrevious research has revealed that patients with acute my
Oncologists demand more education on the use of biosimilars. ESMO takes action

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ

Oncologists demand more education on the use of biosimilars. ESMO takes action

byEuropean Society for Medical OncologyCredit: CC0 Public DomainBiological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targ
Advancing cervical cancer prevention in China: New insights and future strategies

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the
Patients in lower-income countries receive less timely cancer diagnoses

Patients in lower-income countries receive less timely cancer diagnoses

byPublic Library of ScienceCredit: Unsplash/CC0 Public DomainThe time it takes a cancer patient to see a doctor, receive a diagnosis and begin treatment can vary greatly depending on the patient

Patients in lower-income countries receive less timely cancer diagnoses

byPublic Library of ScienceCredit: Unsplash/CC0 Public DomainThe time it takes a cancer patient to see a doctor, receive a diagnosis and begin treatment can vary greatly depending on the patient
Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect
Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo
Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue